Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | NPC1 | O15118 | 6/20 | 0.44 |
| ▸ | RAB9A | P51151 | 5/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 3/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.41 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.41 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.40 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1802256 | 0.88 | KMT2A (0.47) | KMT2ALMNATSHRMAPTKDM4E | |
| SCHEMBL1804359 | 0.87 | CYP1A2 (0.49) | KMT2AMEN1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL1805191 | 0.85 | OPRM1 (0.48) | KMT2ALMNAMEN1NPC1RAB9A | |
| SCHEMBL1802753 | 0.81 | NR3C2 (0.40) | KMT2ALMNANPC1SMN1; SMN2TSHR | |
| SCHEMBL21899368 | 0.79 | CTNNB1 (0.40) | KMT2AMEN1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL1805166 | 0.79 | NSD2 (0.43) | KMT2ANPC1RAB9ASMN1; SMN2TSHR | |
| SCHEMBL12551321 | 0.79 | KMT2A (0.39) | KMT2ALMNAMEN1NPC1RAB9A | |
| SCHEMBL27919385 | 0.79 | TSHR (0.48) | KMT2AMEN1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL25208675 | 0.77 | KMT2A (0.51) | KMT2ALMNASMN1; SMN2TSHRMAPT | |
| SCHEMBL1805967 | 0.74 | SMN1; SMN2 (0.64) | KMT2ALMNAMEN1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2322502-B1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS AGRO INC (JP) | 2019-09-18 | — | — | EP | disclosed |
| EP-2322502-B1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS AGRO INC (JP) | 2019-09-18 | — | — | EP | disclosed |
| US-9890110-B2 | Method for producing amide derivative | MITSUI CHEMICALS AGRO, INC. (JP) | 2018-02-13 | — | — | US | disclosed |
| US-9890110-B2 | Method for producing amide derivative | MITSUI CHEMICALS AGRO, INC. (JP) | 2018-02-13 | — | — | US | disclosed |
| US-9890110-B2 | Method for producing amide derivative | MITSUI CHEMICALS AGRO, INC. (JP) | 2018-02-13 | — | — | US | disclosed |
| US-20160297750-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2016-10-13 | — | — | US | disclosed |
| US-20160297750-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2016-10-13 | — | — | US | disclosed |
| US-20160297750-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2016-10-13 | — | — | US | disclosed |
| US-9394240-B2 | Method for producing amide derivative | MITSUI CHEMICALS AGRO, INC. (JP) | 2016-07-19 | — | — | US | disclosed |
| US-9394240-B2 | Method for producing amide derivative | MITSUI CHEMICALS AGRO, INC. (JP) | 2016-07-19 | — | — | US | disclosed |
| US-8853440-B2 | Method for producing amide derivative | MITSUI CHEMICALS AGRO, INC. (JP) | 2014-10-07 | — | — | US | disclosed |
| US-8853440-B2 | Method for producing amide derivative | MITSUI CHEMICALS AGRO, INC. (JP) | 2014-10-07 | — | — | US | disclosed |
| US-20140296560-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2014-10-02 | — | — | US | disclosed |
| US-20140296560-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2014-10-02 | — | — | US | disclosed |
| US-20140296560-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2014-10-02 | — | — | US | disclosed |
| US-20110137068-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS AGRO, INC. (JP) | 2011-06-09 | — | — | US | disclosed |
| US-20110137068-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS AGRO, INC. (JP) | 2011-06-09 | — | — | US | disclosed |
| US-20110137068-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | MITSUI CHEMICALS AGRO, INC. (JP) | 2011-06-09 | — | — | US | disclosed |
| EP-2322502-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | Mitsui Chemicals Agro, Inc. (JP) | 2011-05-18 | — | — | EP | disclosed |
| EP-2322502-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | Mitsui Chemicals Agro, Inc. (JP) | 2011-05-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140296560-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | AFF4, AFF1, AFF2 | KMT2A 1316/4885LMNA 2033/4885MEN1 2532/4885 |
| US-20160297750-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | AFF4, AFF1, AFF2 | KMT2A 1316/4885LMNA 2033/4885MEN1 2532/4885 |
| US-20110137068-A1 | METHOD FOR PRODUCING AMIDE DERIVATIVE | AFF4, AFF1, AFF2 | KMT2A 1316/4885LMNA 2033/4885MEN1 2532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.